Liposomes Characterization Including the Size and Zeta Potential Characterisation of Anionic and Cationic Liposomes Using the Zetasizer Nano

Liposomes are vesicles composed of a bilayer of lipid molecules enclosing an aqueous volume. They were initially used as model systems to study membrane properties such as permeability. Recent applications have concentrated on their use as drug delivery vehicles due to the ability of incorporating water-soluble materials in their aqueous volume or oil soluble materials in the lipid bilayer. Liposomes can be designed for specific applications through control of the lipid composition or modification of the surface by conjugation of antibodies or peptides. For example, cationic liposomes are used in gene therapy applications due to their ability to complex to DNA.

Properties that Effect the Fate of Intravenously Injected Liposomes

The fate of intravenously injected liposomes is determined by a number of properties. Two of the most important are particle size and zeta potential. Both of these parameters can be measured on the Zetasizer Nano range of instruments. Particle size is measured using dynamic light scattering (DLS). This technique measures the time-dependent fluctuations in the intensity of scattered light which occur because the particles are undergoing Brownian motion. Analysis of these intensity fluctuations enables the determination of the diffusion coefficients of the particles which are converted into a size distribution.

Measuring Zeta Potential of Liposomes

The zeta potential of a particle is the overall charge that the particle acquires in a particular medium. Knowledge of the zeta potential of a liposome preparation can help to predict the fate of the liposomes in vivo. Measurement of the zeta potential of samples in the Zetasizer Nano is done using the technique of laser Doppler velocimetry. In this technique, a voltage is applied across a pair of electrodes at either end of a cell containing the particle dispersion. Charged particles are attracted to the oppositely charged electrode and their velocity is measured and expressed in unit field strength as their electrophoretic mobility. Further information on these techniques can be found in other application and technical notes on the Malvern Panalytical website.

This application note summarizes size and zeta potential measurements made on both anionic and cationic liposomes.

Experimental

Liposome Preparation

Liposomes were prepared by the sonication method. A series of anionic liposomes were prepared from various mixtures of dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylglycerol in phosphate buffered saline (PBS) as detailed in table 1. Cationic liposomes were prepared from DPPC, cholesterol and the cationic surfactant dimethyl dioctadecylammonium bromide (DDAB) as summarized in table 2. In all cases the final concentrations of the liposomes were 4mg lipid/ml PBS.

Table 1. Weights of DPPC and DPPG used in the preparation of a series of anionic liposomes in phosphate buffered saline (PBS).

DPPC (mg)

DPPG (mg)

DPPG (mole %)

PBS (ml)

19

1

5.2

5

18

2

10.9

5

17

3

17.4

5

16

4

24.6

5

15

5

32.8

5

Table 2. Weights of DPPC, cholesterol and DDAB used in the preparation of a series of cationic liposomes in phosphate buffered saline (PBS).

DPPC (mg)

Cholesterol (mg)

DDAB (mg)

DDAB (mole %)

PBS (ml)

17

2

1

5.6

5

16

2

2

11.8

5

15

2

3

18.6

5

14

2

4

26.1

5

13

2

5

34.6

5

The lipids were dissolved and mixed in chloroform (DPPG was dissolved in a mixture of chloroform/methanol (2:1 v/v)) and the solvent removed by rotary evaporation at 60°C to obtain a thin lipid film. The appropriate volume of phosphate buffered saline (preheated at 60°C) was added and the vessel vigorously agitated on a rotary mixer to produce multilamellar vesicles (MLVs). The MLVs were then bath sonicated at 60°C for 15 minutes to produce unilamellar liposomes. After sonication, the liposome samples were incubated at 60°C for 15 minutes to allow them to anneal.

Liposome Characterization

All sizing and zeta potential measurements were made on a Zetasizer Nano ZS at 25°C. Sizing measurements were made on the neat liposome samples, whereas the samples were diluted 1 in 10 with PBS for the zeta potential measurements. The Nano ZS incorporates non-invasive backscatter (NIBS™) optics for sizing measurements. The detection angle of 173°enables size measurements of concentrated, turbid samples to be made. However, the scattered light detected from samples during a zeta potential measurement is made at the forward angle of 12°. Therefore the laser beam needs to penetrate the sample and as a consequence, the sample concentration for zeta potential measurements must be lower than that for sizing.

Results

Anionic Liposomes

The results of the particle sizing and zeta potential measurements of the various anionic liposomes are summarized in table 3. This table shows the z-average diameters (the mean diameters based upon the intensity of scattered light), the polydispersity index (an estimate of the width of the distribution) and the mean zeta potential values obtained for the various liposome samples. The z-average diameter values are the means of 3 repeat measurements (standard deviations in brackets) made on the neat liposome samples. The zeta potential values are the means of 5 repeat measurements (standard deviations in brackets) made on diluted samples (1 in 10 with PBS).

Table 3. The z-average diameters in nm, polydispersity index values and zeta potentials in mV of various anionic liposomes prepared in PBS. The standard deviation values from the repeat measurements are shown in brackets.

Mole % DPPG

z-Av Dia in nm (SD)

Polydispersity (SD)

Zeta Potential in mV (SD)

5.2

133.8 (0.4)

0.292 (0.01)

-9.0 (0.64)

10.9

92.3 (0.49)

0.269 (0.01)

-15.7 (1.36)

17.4

107.2 (0.20)

0.256 (0.01)

-22.5 (0.95)

24.6

125.1 (0.60)

0.261 (0.01)

-27.3 (1.29)

32.8

89.2 (1.39)

0.264 (0.01)

-31.4 (0.98)

The sizing results obtained for these anionic liposome preparations show that the bath sonication method of preparation gives similar size means and distribution widths.

The zeta potential and size values are plotted in figure 1 as a function of the mole% DPPG. The data shows that the measurements are very repeatable for each liposome sample and show the expected trend of becoming more negatively charged with increasing DPPG content. In addition, the results show that the size is independent of the liposome composition.

Zeta potential and size values obtained as a function of the mole% DPPG content for a series of anionic liposomes.

Figure 1. Zeta potential and size values obtained as a function of the mole% DPPG content for a series of anionic liposomes.

Cationic Liposomes

Table 4 summarises the sizing and zeta potential results obtained for the series of cationic liposomes. Similar size distributions were obtained compared to the anionic liposome preparations. Figure 2 shows a plot of the zeta potential and size results obtained as a function of the mole% DDAB and shows a gradual increase in positive charge as the DDAB content of the liposomes increases.

Table 4. The z-average diameters in nm, polydispersity index values and zeta potentials in mV of various cationic liposomes prepared in PBS. The standard deviation values from the repeat measurements are shown in brackets.

Mole % DDAB

z-Av Dia in nm (SD)

Polydispersity (SD)

Zeta Potential in mV (SD)

5.6

116.6 (1.0)

0.258 (0.01)

10.3 (0.88)

11.8

95.8 (0.36)

0.223 (0.01)

20.1 (1.36)

18.6

120.3 (0.40)

0.266 (0.01)

25.9 (0.52)

26.1

109.0 (1.15)

0.270 (0.01)

33.1 (2.2)

34.6

104.0 (0.42)

0.251 (0.01)

39.5 (1.2)

Zeta potential and size values obtained as a function of the mole% DDAB content for a series of cationic liposomes.

Figure 2. Zeta potential and size values obtained as a function of the mole% DDAB content for a series of cationic liposomes.

Conclusions

The physical characterization of liposomes is of great importance in understanding their suitability for a range of applications. Knowledge of the zeta potential of a liposome preparation can help to predict the fate of the liposomes in vivo. Association of charged liposomes with oppositely charged molecules can be monitored by measuring the zeta potential of the resulting complex.

The Zetasizer Nano series enables the rapid and repeatable characterization of both size and zeta potential of liposomes as detailed in this application note.

This information has been sourced, reviewed and adapted from materials provided by Malvern Panalytical.

For more information please visit Malvern Panalytical.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Malvern Panalytical. (2024, March 01). Liposomes Characterization Including the Size and Zeta Potential Characterisation of Anionic and Cationic Liposomes Using the Zetasizer Nano. AZoNano. Retrieved on December 07, 2024 from https://www.azonano.com/article.aspx?ArticleID=1220.

  • MLA

    Malvern Panalytical. "Liposomes Characterization Including the Size and Zeta Potential Characterisation of Anionic and Cationic Liposomes Using the Zetasizer Nano". AZoNano. 07 December 2024. <https://www.azonano.com/article.aspx?ArticleID=1220>.

  • Chicago

    Malvern Panalytical. "Liposomes Characterization Including the Size and Zeta Potential Characterisation of Anionic and Cationic Liposomes Using the Zetasizer Nano". AZoNano. https://www.azonano.com/article.aspx?ArticleID=1220. (accessed December 07, 2024).

  • Harvard

    Malvern Panalytical. 2024. Liposomes Characterization Including the Size and Zeta Potential Characterisation of Anionic and Cationic Liposomes Using the Zetasizer Nano. AZoNano, viewed 07 December 2024, https://www.azonano.com/article.aspx?ArticleID=1220.

Ask A Question

Do you have a question you'd like to ask regarding this article?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.